JPM | Free Full-Text | Local Disease-Free Survival Rate (LSR) Application to Personalize Radiation Therapy Treatments in Breast Cancer Models
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
ASCO GU 2023: FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy and 6 Months of GnRH Agonist with or Without Abiraterone Acetate/prednisone and Apalutamide Post-Radical Prostatectomy
Disease Free Survival - an overview | ScienceDirect Topics
Progression Free Survival
Disease-free survival curve (Kaplan Meier) associated with clusterin... | Download Scientific Diagram
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | NEJM
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients | Aging
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival | BMC Cancer | Full Text
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Kaplan–Meier plots for disease-free survival (DFS) (A) and overall... | Download Scientific Diagram
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time | Scientific Reports
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect
Value-Based Calculators in Cancer: Current State and Challenges | JCO Oncology Practice
View Image
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma | Journal for ImmunoTherapy of Cancer | Full Text
Survival Analysis Basics - Easy Guides - Wiki - STHDA
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
312: Survival After Disease Progression of Patients with Locally Advanced Bladder Cancer Previously Treated with Radical Cystect
JCM | Free Full-Text | The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes | PLOS ONE
